Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2015 / Cilt: 49 - Sayı: 4

Relationship of blood lipid levels with Hba1c and obesity in patients with type 2 diabetes mellitus

Tip 2 Diyabet Hastalarında Kan Lipid Düzeylerinin Hba1c ve Obezite ile İlişkisi

Pages
248–254
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Lipid profile was adversely effected in diabetic patients having obesity and poor glycemic control.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Dyslipidemia play an important role in the development of coronary artery disease (CAD) which is the world’s leading cause of mortality.
📊
Key Findings & Data:Material and Method: One hundred and sixty five patients (82 male) who admitted to Istanbul Education and Research Hospital Outpatient Diabetes department, whose known diabetes age was less than 5 years, not taking any anti-lipidemic medicine in the last 6 months, not having ischemic heart disease, diabetes controlled by only oral antidiabetics, non-smoker and not drinking alcohol, don’t having any endocrine disorder with possible affect on blood lipid levels, were enrolled to the study.
💡
Conclusion & Impact:Lipid profile was adversely effected in diabetic patients having obesity and poor glycemic control.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Dyslipidemia play an important role in the development of coronary artery disease (CAD) which is the world’s leading cause of mortality. Diabetes mellitus and obesity can cause CAD by dif- ferent ways; dyslipidemia is common in both of them, that can lead to CAD. We investigate the effect of obesity and poor glycemic control on lipid profile in diabetic patients, in our country. Material and Method: One hundred and sixty five patients (82 male) who admitted to Istanbul Education and Research Hospital Outpatient Diabetes department, whose known diabetes age was less than 5 years, not taking any anti-lipidemic medicine in the last 6 months, not having ischemic heart disease, diabetes controlled by only oral antidiabetics, non-smoker and not drinking alcohol, don’t having any endocrine disorder with possible affect on blood lipid levels, were enrolled to the study. The relationship between lipid levels and HbA1c, body mass index (BMI) and diabetes age were assessed. Student’s t test, ANOVA and Pearson correlation tests were used for comparisons. p<0.05 was considered significant. Results: It was determined that when BMI value increased, cholesterol, triglyceride and LDL levels increased (r=0.46 p<0.001, r=0.58 p<0.001, r=0.34 p<0.01, respectively) and HDL levels decreased (r=-0.37 p<0.001 ). In patients having high HbA1c levels, total cholesterol, triglyceride and LDL choles- terol levels were found high (r=0.27 p<0.001, r=0.29 p<0.001, r=0.20 p<0.05, respectively). A positive correlation was found between the increasing diabetes age and HbA1c levels (r=0.28, p <0.001) was determined, but no significant corelation with blood lipid levels was detected. Conclusion: We found similar but not identical results with previous international studies, in this study done in our country. Lipid profile was adversely effected in diabetic patients having obesity and poor glycemic control.

Özet

Tip 2 diyabet hastalarında kan lipid düzeylerinin Hba1c ve obezite ile ilişkisi Amaç: Dislipidemi, dünyadaki bir numaralı mortalite nedeni olan koroner arter hastalığının (KAH) gelişiminde önemli yere sahiptir. Diyabet ve obezite farklı yollarla KAH gelişimine neden olmakla bir- likte, dislipidemi KAHna neden olan ortak yönlerinden biridir. Biz de ülkemizde diyabet hastalarında obezite ve kötü glisemik kontrolün lipid profili üzerinde nasıl bir etki yaptığını araştırdık. Gereç ve Yöntem: İstanbul Eğitim ve Araştırma Hastanesi Diyabet Polikliniğine başvuran, bilinen diya- bet yaşı 5‘i geçmeyen, son 6 ay içerisinde herhangi bir hiperlipidemi tedavisi almayan, kanıtlanmış iske- mik kalp hastalığı olmayan, sadece oral antidiyabetik ilaç kullanan, sigara ve alkol kullanmayan, kan lipid düzeyini etkileyecek bilinen bir endokrin bozukluğu olmayan 82si erkek 165 hasta alındı. Lipid düzeyleri ile HbA1c, vücut kitle indeksi (VKİ) ve diyabet yaşı arasındaki ilişkiler değerlendirildi. Karşılaştırmalarda students t, ANOVA ve Pearson korelasyon testleri kullanıldı. p<0.05 anlamlı kabul edildi. Bulgular: VKİ değerleri arttıkça total kolesterol, trigliserid ve LDL kolesterol düzeylerinin de arttığı (r=0.46 p<0.001, r=0.58 p<0.001, r=0.34 p<0.01, sırasıyla), HDL kolesterol düzeylerinin ise düştüğü saptandı (r=-0.37 p<0.001). HbA1c değeri yüksek olan hastalarda total kolesterol, trigliserid ve LDL kolesterol düzeylerinin yüksek olduğu (r=0.27 p<0.001, r=0.29 p<0.001, r=0.20 p<0.05, sırasıyla) görüldü. Diyabet yaşı artıkça HbA1c düzeyleri arasında doğru bir orantı (r=0.28 p<0.001) saptanırken, kan lipid düzeyinde anlamlı bir ilişki saptanmadı. Sonuç: Ülkemizde yaptığımız bu çalışmada bire bir olmasa da daha önce yapılan uluslararası çalışma- larla benzer sonuçlara ulaştık. Obez ve kötü glisemik kontrole sahip diyabet hastalarında lipid profili olumsuz etkilenmektedir.

🔖

Cite This Article

ÖZDOĞAN, E., ÖZDOĞAN, O., ALTUNOĞLU, E. G., KÖKSAL, A. R. (2015). Relationship of blood lipid levels with Hba1c and obesity in patients with type 2 diabetes mellitus. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 49 - Sayı: 4, 248–254. https://ajindex.com/articles/363826

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. King H, Aubert RF, Herman WH. Global burden of diabetes 1995-2025. Diabetes care 1998; 21: 1414-31
  2. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013; 28: 169-80
  3. Seidell JC, Rissanen AM; Time trends in worldwide prevalence of obesity; in Bray GA, Bouchard C, James WPT (eds): Handbook of Obesity. New York, Marcel Dekker 1998; p79-91
  4. Onat A, Keleş I, Sansoy V, Ceyhan K, Uysal O, Cetinkaya A, et al. Rising obesity indices in 10-year follow-up of Turkish men and women: Body mass index independent predictor of coronary events among men. Türk Kardiyoloji Derneği Arşivi 2001; 29: 430-36
  5. Thompson D, Edelsberg J, Colditz GA. Lifetime health and economic consequence of obesity. Arch Intern Med 1999; 159: 2177-813
  6. Kültürsay H, Yavuzgil O. Obezite ve Kardiyovasküler Risk. Türk Kardiyoloji Seminerleri 2003; 3: 129-35
  7. Smith SR. Obesity: The endokrinology of obesity. Endokrinology and Metabolism Clinics of North America 1996; 25: 921-42
  8. Grundy SM: Pathogenesis of atherojenic dyslipidemia. Drug Benefit Trends 2000; 12: 22-7
  9. Ginsberg HN. İnsulin resistance and cardiovascular disease. J Clin Invest 2000; 106; 453-8
  10. Syvanne M, Taskinen M-R. Lipids and lipoproteins and coronary risk factors in non-insulin dependent diabetes mellitus. Lancet 1997; 350(Supp 1): S120-3
  11. Gotto AM Jr, Moon JE. Management of cardiovascular risk: the importance of meeting lipid targets. Am J Cardiol 2012; 110(Supp l): 3-14
  12. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. AHA Scientific statement. Diabetes and cardivascular disease. A Steatment for healtcare professionals from the American Heart Association. Circulation 1999; 100: 1134-46
  13. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004; 14: 421-31
  14. Denke MA, Sempos CT, Grundy SM. Excess body weight: an underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med 1993; 153: 1093-103
  15. Garrison RJ, Wilson PW, Castelli WP, Feinleib M, Kannel WB, McNamara PM. Obesity and lipoprotein cholesterol in the Framingham Offspring Study. Metabolism 1980; 29: 1053-60
  16. Stern MP, Haffner SM. Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiov